KAPA vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

KAPA

44.7
AI Score
VS
NIVF Wins

NIVF

45.6
AI Score

Investment Advisor Scores

KAPA

45score
Recommendation
HOLD

NIVF

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric KAPA NIVF Winner
Net Income -1.65M 9.88M NIVF
Operating Income -1.69M -10.73M KAPA
ROE -31.1% 37.1% NIVF
ROA -28.8% 30.2% NIVF
Total Assets 5.74M 32.72M NIVF
Cash 3.67M 758,621 KAPA
Current Ratio 10.31 3.12 KAPA

Relative Price Performance (Last 90 Days)

KAPA 1M: -15.8% · 3M: -45.0% NIVF 1M: +41.4% · 3M: -61.9%

Current Technical Phase

KAPA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.0%), weak momentum, RSI 42

RSI (14): 41.6 · Price: $0.31

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.2 · Price: $0.65

Fundamentals Snapshot

Metric KAPA NIVF
Market Cap
Forward P/E -0.5 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2%
Operating Margin 0.0% -3.5%
EPS -0.30 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.